Found 78 matching trials
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib EARLY_PHASE1 Background:
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymph...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma PHASE2 B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Show More Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Learn More & Join Trial
Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants PHASE1 The main purpose of this study is to learn about how itraconazole and rifam...
Show More Location
Covance Clinical Research Unit
Learn More & Join Trial
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma PHASE4 This study will evaluate the long-term safety of pirtobrutinib in participa...
Show More Location
Mitchell Cancer Institute
Learn More & Join Trial
Mosunetuzumab for CLL MRD Clearance PHASE1 The goal of this study is to test mosunetuzumab given alone or in combinati...
Show More Location
Brigham & Women's Hospital
Learn More & Join Trial
Study of Oral LOXO-338 in Patients With Advanced Blood Cancers PHASE1 The purpose of this study is to find out whether the study drug, LOXO-338, ...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-Glycoprotein Substrate) in Healthy Participants PHASE1 The main purpose of this study is to evaluate the effect of Pirtobrutinib (...
Show More Location
Covance Clinical Research Unit
Learn More & Join Trial
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) PHASE3 This is a study for participants with a type of blood cancer called mantle ...
Show More Status
Active Not Recruiting
Location
Alaska Oncology and Hematology, LLC
Learn More & Join Trial
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL PHASE3 This is a Phase 3, randomized, open-label, multicenter study comparing rocb...
Show More Location
Orchard Healthcare Research
Learn More & Join Trial
Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia PHASE2 This phase II trial studies how well pirtobrutinib and venetoclax work in t...
Show More Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Learn More & Join Trial